Generic drugs are facing explosive growth The future prospects of pharmaceutical intermediates are promising

Pharmaceutical intermediates have attracted much attention and favor from all walks of life. Our government also attaches great importance to the development of pharmaceutical intermediates and has introduced a series of policies and measures to encourage them. Under the strong promotion of the government, China's pharmaceutical intermediates industry is developing rapidly. At present, has basically met the needs of pharmaceutical production of chemical raw materials and intermediates.
According to the "China Pharmaceutical Intermediates Industry Market Research and Investment Analysis Report" released by the Forward-Looking Industrial Research Institute, with the expiration of patented drugs, in the next five to ten years, generic drugs will usher in explosive growth with price advantage, production and sales are expected to soar. The outbreak of generic drugs will bring a broader market space and good development opportunities for pharmaceutical intermediates, and the future prospects are promising.
pharmaceutical intermediate refers to some chemical raw materials or chemical products used in the process of pharmaceutical synthesis process, and is also an important part of fine chemical industry, which has gradually become the core of the development of chemical industry in various countries. In recent years, China has made great progress in fine chemical industry, and the rate of refinement has been continuously improved, creating a good atmosphere for the development of pharmaceutical intermediates.
, because of the high investment efficiency, high profit margin, high value-added characteristics, pharmaceutical intermediates have attracted attention and favor from all walks of life. Our government also attaches great importance to the development of pharmaceutical intermediates and has introduced a series of policies and measures to encourage them.
promoted by the government, China's pharmaceutical intermediates industry is developing rapidly. At present, has basically met the needs of pharmaceutical production of chemical raw materials and intermediates, and presents the following six characteristics.
first, pharmaceutical intermediate enterprises are mostly private enterprises, the scale of investment is generally small, the investment amount is basically in the millions to 12 million, but the operation is more flexible, can quickly and effectively cope with market changes;
second, the distribution of pharmaceutical intermediate enterprises is more concentrated, mainly in Jiangsu and Zhejiang, especially in Taizhou, Zhejiang Province, Jiangsu Jintan two places, a large number of pharmaceutical intermediate enterprises;
, pharmaceutical intermediate enterprises face environmental pressure gradually increased, the construction of environmental protection treatment facilities is imperative;
, product update iteration is fast, new varieties emerge endlessly, forcing pharmaceutical intermediate enterprises to follow up or improve the process;
, the pharmaceutical intermediates industry is fierce and disorderly, more and more small and medium-sized chemical enterprises are joining them, is not conducive to the cluster development of the pharmaceutical intermediates industry;
, pharmaceutical intermediate enterprises generally lack innovation, there is a low level of duplication, in the world with independent intellectual property rights of intermediate drugs are few.
the above-mentioned development characteristics, China's pharmaceutical intermediates and the international advanced level is still far from. In promoting the development of the pharmaceutical intermediates industry in the future, we should attach importance to scientific research input, set up engineering centers with interdisciplinary, multi-directional and high starting point as the standard, provide a platform for the birth of new products, and carry out prediction and evaluation work to achieve the rapid and healthy development of pharmaceutical intermediates.
, pharmaceutical intermediates are expected to benefit as Chinese pharmaceutical companies work to replicate them, but until then, overcapacity and vicious competition need to be addressed. (Forward Industry Research Institute)